
Maravai LifeSciences Holdings, Inc.: shareholders and insiders
Price
$7.19
November 19, 2026Market cap $1.0B
What Ploutos Investor adds for Maravai LifeSciences
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 12, 2026, from their own Form 4 filings.
Bought on the market
$368.5K
1 person
Sold on the market
$254.0K
1 person
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $254.0K by 1 person
- 2025: bought $368.5K by 1 person, no sales
- 2026: no buys, sold $254.0K by 1 person
- Nov 9, 2026Bernd BrustChief Executive OfficerKind
- Oct 30, 2026Rajesh AsarpotaChief Financial OfficerKind
- Oct 8, 2026Bernd BrustChief Executive OfficerKind
- Sep 30, 2026Rajesh AsarpotaChief Financial OfficerKind
- Sep 8, 2026Bernd BrustChief Executive OfficerKind
- Aug 31, 2026Rajesh AsarpotaChief Financial OfficerKind
- Aug 10, 2026Bernd BrustChief Executive OfficerKind
- Jul 30, 2026Rajesh AsarpotaChief Financial OfficerKind
- Jul 8, 2026Bernd BrustChief Executive OfficerKind
- Jun 30, 2026Rajesh AsarpotaChief Financial OfficerKind
- Jun 10, 2026Kurt OreshackGeneral CounselKind10b5-1
- Jun 9, 2026Kurt OreshackGeneral CounselKind10b5-1
- Jun 9, 2026Gregory T LucierDirectorKind
- Jun 9, 2026Gregory T LucierDirectorKind
- Jun 8, 2026Bernd BrustChief Executive OfficerKind
- May 26, 2026Luke Joseph MarkerDirectorKind
- May 26, 2026Susannah GrayDirectorKind
- May 26, 2026Constantine S MihasDirectorKind
- May 26, 2026R Andrew EckertDirectorKind
- May 26, 2026Gregory T LucierDirectorKind
- May 26, 2026Sean Laurence CunninghamDirectorKind
- May 26, 2026John A DeFordDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Bernd BrustChief Executive Officer | 29.3K | $7.52 | $220.0K | Form 4 | |
| Oct 30, 2026 | Rajesh AsarpotaChief Financial Officer | 5,466 | $8.46 | $46.2K | Form 4 | |
| Oct 8, 2026 | Bernd BrustChief Executive Officer | 29.3K | $7.43 | $217.3K | Form 4 | |
| Sep 30, 2026 | Rajesh AsarpotaChief Financial Officer | 5,465 | $7.65 | $41.8K | Form 4 | |
| Sep 8, 2026 | Bernd BrustChief Executive Officer | 29.3K | $7.32 | $214.1K | Form 4 | |
| Aug 31, 2026 | Rajesh AsarpotaChief Financial Officer | 5,465 | $7.68 | $42.0K | Form 4 | |
| Aug 10, 2026 | Bernd BrustChief Executive Officer | 29.3K | $6.23 | $182.2K | Form 4 | |
| Jul 30, 2026 | Rajesh AsarpotaChief Financial Officer | 5,465 | $6.59 | $36.0K | Form 4 | |
| Jul 8, 2026 | Bernd BrustChief Executive Officer | 29.3K | $5.92 | $173.2K | Form 4 | |
| Jun 30, 2026 | Rajesh AsarpotaChief Financial Officer | 65.6K | $6.39 | $419.1K | Form 4 | |
| Jun 10, 2026 | Kurt OreshackGeneral Counsel | 10b5-1 | 25.0K | $5.10 | $127.5K | Form 4 |
| Jun 9, 2026 | Kurt OreshackGeneral Counsel | 10b5-1 | 25.0K | $5.06 | $126.5K | Form 4 |
| Jun 9, 2026 | Gregory T LucierDirector | 46.3K | – | – | Form 4 | |
| Jun 9, 2026 | Gregory T LucierDirector | 46.3K | – | – | Form 4 | |
| Jun 8, 2026 | Bernd BrustChief Executive Officer | 351.0K | $5.02 | $1.8M | Form 4 | |
| May 26, 2026 | Luke Joseph MarkerDirector | 46.3K | – | – | Form 4 | |
| May 26, 2026 | Susannah GrayDirector | 46.3K | – | – | Form 4 | |
| May 26, 2026 | Constantine S MihasDirector | 46.3K | – | – | Form 4 | |
| May 26, 2026 | R Andrew EckertDirector | 46.3K | – | – | Form 4 | |
| May 26, 2026 | Gregory T LucierDirector | 46.3K | $4.38 | $202.8K | Form 4 | |
| May 26, 2026 | Sean Laurence CunninghamDirector | 46.3K | – | – | Form 4 | |
| May 26, 2026 | John A DeFordDirector | 46.3K | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 28, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by MRVI's officers and directors from 2020 up to November 19, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class5.90%
- Millennium Management LLCwith 2 more personsClass A Common Stock, par value $0.01 per shareShare of class5.20%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.90% | 8.58M | Oct 17, 2025 | 13G/A | |
| Millennium Management LLCwith 2 more personsClass A Common Stock, par value $0.01 per share | 5.20% | 7.77M | Sep 29, 20264 filings since May 12, 2026 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Millennium Mgmt (Englander)In the quarter+17%
- Renaissance TechnologiesIn the quarter-13%
- Point72 (Cohen)In the quarter+25%
- Citadel Advisors (Griffin)In the quarter-12%
- AQR CapitalIn the quarter+20%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Millennium Mgmt (Englander) | 7.62M | +17% | $58M | 0.04% |
| Renaissance Technologies | 3.99M | -13% | $31M | 0.04% |
| Point72 (Cohen) | 2.51M | +25% | $19M | 0.03% |
| Citadel Advisors (Griffin) | 1.86M | -12% | $14M | 0.01% |
| AQR Capital | 101.8K | +20% | $800.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 9.25% of its shares outstanding were held short, -3.5% since the report before.
- Shares held short
- 13.35M
- 9.25%
- Since the report before13.83M on Sep 30, 2026
- -3.5%
- 4.5
- 3.00M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 54%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 7.64M
- Nov 15, 2023: Shares held short 7.28M
- Nov 30, 2023: Shares held short 5.93M
- Dec 15, 2023: Shares held short 5.98M
- Dec 29, 2023: Shares held short 6.11M
- Jan 12, 2024: Shares held short 6.63M
- Jan 31, 2024: Shares held short 6.83M
- Feb 15, 2024: Shares held short 6.21M
- Feb 29, 2024: Shares held short 6.20M
- Mar 15, 2024: Shares held short 7.35M
- Mar 28, 2024: Shares held short 5.12M
- Apr 15, 2024: Shares held short 6.34M
- Apr 30, 2024: Shares held short 7.13M
- May 15, 2024: Shares held short 6.74M
- May 31, 2024: Shares held short 6.13M
- Jun 14, 2024: Shares held short 6.18M
- Jun 28, 2024: Shares held short 6.88M
- Jul 15, 2024: Shares held short 8.07M
- Jul 31, 2024: Shares held short 7.92M
- Aug 15, 2024: Shares held short 8.44M
- Aug 30, 2024: Shares held short 8.38M
- Sep 13, 2024: Shares held short 7.91M
- Sep 30, 2024: Shares held short 9.22M
- Oct 15, 2024: Shares held short 8.97M
- Oct 31, 2024: Shares held short 8.22M
- Nov 15, 2024: Shares held short 6.96M
- Nov 29, 2024: Shares held short 7.90M
- Dec 13, 2024: Shares held short 8.29M
- Dec 31, 2024: Shares held short 8.51M
- Jan 15, 2025: Shares held short 8.92M
- Jan 31, 2025: Shares held short 8.54M
- Feb 14, 2025: Shares held short 10.30M
- Feb 28, 2025: Shares held short 8.82M
- Mar 14, 2025: Shares held short 11.60M
- Mar 31, 2025: Shares held short 13.13M
- Apr 15, 2025: Shares held short 13.95M
- Apr 30, 2025: Shares held short 14.24M
- May 15, 2025: Shares held short 14.60M
- May 30, 2025: Shares held short 13.67M
- Jun 13, 2025: Shares held short 13.05M
- Jun 30, 2025: Shares held short 13.75M
- Jul 15, 2025: Shares held short 14.38M
- Jul 31, 2025: Shares held short 13.31M
- Aug 15, 2025: Shares held short 13.50M
- Aug 29, 2025: Shares held short 13.88M
- Sep 15, 2025: Shares held short 14.38M
- Sep 30, 2025: Shares held short 13.10M
- Oct 15, 2025: Shares held short 13.43M
- Oct 31, 2025: Shares held short 12.99M
- Nov 14, 2025: Shares held short 13.28M
- Nov 28, 2025: Shares held short 12.28M
- Dec 15, 2025: Shares held short 12.76M
- Dec 31, 2025: Shares held short 11.56M
- Jan 15, 2026: Shares held short 12.28M
- Jan 30, 2026: Shares held short 11.29M
- Feb 13, 2026: Shares held short 10.95M
- Feb 27, 2026: Shares held short 10.64M
- Mar 13, 2026: Shares held short 9.72M
- Mar 31, 2026: Shares held short 9.51M
- Apr 15, 2026: Shares held short 9.24M
- Apr 30, 2026: Shares held short 8.88M
- May 15, 2026: Shares held short 8.51M
- May 29, 2026: Shares held short 7.87M
- Jun 15, 2026: Shares held short 8.65M
- Jun 30, 2026: Shares held short 8.81M
- Jul 15, 2026: Shares held short 9.27M
- Jul 31, 2026: Shares held short 8.51M
- Aug 14, 2026: Shares held short 9.38M
- Aug 31, 2026: Shares held short 10.96M
- Sep 15, 2026: Shares held short 12.37M
- Sep 30, 2026: Shares held short 13.83M
- Oct 15, 2026: Shares held short 13.35M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading39.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 39.0% of the shares in the reported trades were short sales, against 38.7% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 39.0%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 38.7%
- Change
- +0.3 pts
- Short sales a dayon average, of 724.0K shares
- 282.1K
- More than atof 3,666 US-listed companies, same days
- 17%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 22%
- Oct 14, 2026: Short sales 25.2%
- Oct 15, 2026: Short sales 40.8%
- Oct 16, 2026: Short sales 50.1%
- Oct 19, 2026: Short sales 63.1%
- Oct 20, 2026: Short sales 44.8%
- Oct 21, 2026: Short sales 59.7%
- Oct 22, 2026: Short sales 41.6%
- Oct 23, 2026: Short sales 54.8%
- Oct 26, 2026: Short sales 64.2%
- Oct 27, 2026: Short sales 41.9%
- Oct 28, 2026: Short sales 20%
- Oct 29, 2026: Short sales 46.2%
- Oct 30, 2026: Short sales 46.6%
- Nov 2, 2026: Short sales 22.8%
- Nov 3, 2026: Short sales 33.3%
- Nov 4, 2026: Short sales 49%
- Nov 5, 2026: Short sales 34.9%
- Nov 6, 2026: Short sales 44%
- Nov 9, 2026: Short sales 40.8%
- Nov 10, 2026: Short sales 47.5%
- Nov 11, 2026: Short sales 47.8%
- Nov 12, 2026: Short sales 33.2%
- Nov 13, 2026: Short sales 40.9%
- Nov 16, 2026: Short sales 38.2%
- Nov 17, 2026: Short sales 42.8%
- Nov 18, 2026: Short sales 45.7%
- Nov 19, 2026: Short sales 30.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Bernd BrustChief Executive OfficerDirectly1.97M
- Rajesh AsarpotaChief Financial OfficerDirectly412.6K
- R Andrew EckertDirectorDirectly412.2K
- Kurt OreshackGeneral CounselDirectly335.8K
- Gregory T LucierDirectorDirectly311.2K
- Susannah GrayDirectorDirectly216.2K
- John A DeFordDirectorDirectly205.5K
- Luke Joseph MarkerDirectorDirectly184.3K
- Constantine S MihasDirectorDirectly184.3K
- Sean Laurence CunninghamDirectorDirectly184.3K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Bernd BrustChief Executive Officer | 1.97M | – | Nov 9, 2026 | Form 4 |
| Rajesh AsarpotaChief Financial Officer | 412.6K | – | Oct 30, 2026 | Form 4 |
| R Andrew EckertDirector | 412.2K | – | May 26, 2026 | Form 4 |
| Kurt OreshackGeneral Counsel | 335.8K | – | Jun 10, 2026 | Form 4 |
| Gregory T LucierDirector | 311.2K | – | Jun 9, 2026 | Form 4 |
| Susannah GrayDirector | 216.2K | – | May 26, 2026 | Form 4 |
| John A DeFordDirector | 205.5K | – | May 26, 2026 | Form 4 |
| Luke Joseph MarkerDirector | 184.3K | – | May 26, 2026 | Form 4 |
| Constantine S MihasDirector | 184.3K | – | May 26, 2026 | Form 4 |
| Sean Laurence CunninghamDirector | 184.3K | – | May 26, 2026 | Form 4 |
A lower bound: it counts only the 10 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IBBiShares Biotechnology ETFWeight in the fund0.05%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.04%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.03%
- IWMiShares Russell 2000 ETFWeight in the fund0.02%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.02%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- SCHBSchwab U.S. Broad Market ETFWeight in the fund0.00%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
13 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 160
- Q4 2025: Managers 159
- Q1 2026: Managers 160
- Q2 2026: Managers 178
Institutional investors by quarter
The fund managers holding MRVI, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 178 managers held 144M shares, worth $898M. During the quarter 45 opened a position, 27 closed one, 54 added and 51 trimmed.
The largest holders, Q2 2026
- GtcrIn the quarter
- BlackRockIn the quarter+6.7%
- BraidwellIn the quarter-15%
- First Eagle Investment ManagementIn the quarter+191%
- 12 West Capital ManagementIn the quarter-2.8%
- Millennium Mgmt (Englander)In the quarter+295%
- Vanguard Capital ManagementIn the quarter-3.0%
- Ophir Asset Management PtyIn the quarter
- Renaissance TechnologiesIn the quarter+8.0%
- Deutsche Bank Ag\In the quarter+402%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Gtcr | 20.15M | $126M | |
| BlackRock | 9.97M | +6.7% | $62M |
| Braidwell | 8.70M | -15% | $54M |
| First Eagle Investment Management | 7.34M | +191% | $46M |
| 12 West Capital Management | 7.06M | -2.8% | $44M |
| Millennium Mgmt (Englander) | 6.51M | +295% | $41M |
| Vanguard Capital Management | 5.28M | -3.0% | $33M |
| Ophir Asset Management Pty | 4.83M | $30M | |
| Renaissance Technologies | 4.61M | +8.0% | $29M |
| Deutsche Bank Ag\ | 4.30M | +402% | $27M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Maravai LifeSciences's filings show?
Who buys and sells is one part of Maravai LifeSciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have MRVI's insiders bought or sold?
From May 28, 2026 to Nov 12, 2026 Maravai LifeSciences's insiders bought 0 and sold $254.0K of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold MRVI?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $58M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.